Sarah Book to Humans
This is a "connection" page, showing publications Sarah Book has written about Humans.
Connection Strength
0.309
-
Insomnia severity during early abstinence is related to substance use treatment completion in adults enrolled in an intensive outpatient program. J Subst Abuse Treat. 2019 09; 104:97-103.
Score: 0.025
-
Addiction Research Training Programs: Four Case Studies and Recommendations for Evaluation. J Addict Med. 2017 Sep/Oct; 11(5):333-338.
Score: 0.022
-
Patient Perspectives Associated with Intended Duration of Buprenorphine Maintenance Therapy. J Subst Abuse Treat. 2015 Sep; 56:48-53.
Score: 0.019
-
Discontinuation of buprenorphine maintenance therapy: perspectives and outcomes. J Subst Abuse Treat. 2015 May; 52:48-57.
Score: 0.018
-
Pharmacologic treatment of alcoholism. Handb Clin Neurol. 2014; 125:527-42.
Score: 0.017
-
Treating individuals with social anxiety disorder and at-risk drinking: phasing in a brief alcohol intervention following paroxetine. J Anxiety Disord. 2013 Mar; 27(2):252-8.
Score: 0.016
-
Severity of anxiety in mental health versus addiction treatment settings when social anxiety and substance abuse are comorbid. Addict Behav. 2012 Oct; 37(10):1158-61.
Score: 0.015
-
Client attitudes toward alcohol use self-report. Subst Abus. 2012; 33(2):124-9.
Score: 0.015
-
Comorbidity of generalized anxiety disorder and alcohol use disorders among individuals seeking outpatient substance abuse treatment. Addict Behav. 2010 Jan; 35(1):42-5.
Score: 0.013
-
Social anxiety impacts willingness to participate in addiction treatment. Addict Behav. 2009 May; 34(5):474-6.
Score: 0.012
-
Improving acceptance of naltrexone in community addiction treatment centers: a pilot study. J Subst Abuse Treat. 2008 Oct; 35(3):260-8.
Score: 0.011
-
Buprenorphine for postoperative pain following general surgery in a buprenorphine-maintained patient. Am J Psychiatry. 2007 Jun; 164(6):979.
Score: 0.011
-
Paroxetine reduces social anxiety in individuals with a co-occurring alcohol use disorder. J Anxiety Disord. 2008; 22(2):310-8.
Score: 0.011
-
Novel anticonvulsants in the treatment of alcoholism. Expert Opin Investig Drugs. 2005 Apr; 14(4):371-6.
Score: 0.009
-
Effects of pharmacological and genetic regulation of COMT activity in alcohol use disorder: a randomized, placebo-controlled trial of tolcapone. Neuropsychopharmacology. 2022 10; 47(11):1953-1960.
Score: 0.008
-
A preliminary investigation of the role of intraindividual sleep variability in substance use treatment outcomes. Addict Behav. 2022 08; 131:107315.
Score: 0.008
-
The Drug Abuse Research Training (DART) Program for Psychiatry Residents and Summer Fellows: 15-Year Outcomes. Acad Psychiatry. 2022 Jun; 46(3):317-324.
Score: 0.008
-
Effects of Gabapentin on Dorsal Anterior Cingulate Cortex GABA and Glutamate Levels and Their Associations With Abstinence in Alcohol Use Disorder: A Randomized Clinical Trial. Am J Psychiatry. 2021 09 01; 178(9):829-837.
Score: 0.007
-
Sleep and substance use disorder treatment: A preliminary study of subjective and objective assessment of sleep during an intensive outpatient program. Am J Addict. 2021 09; 30(5):477-484.
Score: 0.007
-
Opioid and Dopamine Genes Interact to Predict Naltrexone Response in a Randomized Alcohol Use Disorder Clinical Trial. Alcohol Clin Exp Res. 2020 10; 44(10):2084-2096.
Score: 0.007
-
Efficacy of Gabapentin for the Treatment of Alcohol Use Disorder in Patients With Alcohol Withdrawal Symptoms: A Randomized Clinical Trial. JAMA Intern Med. 2020 05 01; 180(5):728-736.
Score: 0.007
-
Nicotine-Use/Smoking Is Associated with the Efficacy of Naltrexone in the Treatment of Alcohol Dependence. Alcohol Clin Exp Res. 2018 Apr; 42(4):751-760.
Score: 0.006
-
Predictors of Naltrexone Response in a Randomized Trial: Reward-Related Brain Activation, OPRM1 Genotype, and Smoking Status. Neuropsychopharmacology. 2017 Dec; 42(13):2640-2653.
Score: 0.005
-
Engaging medical students in research: reaching out to the next generation of physician-scientists. Acad Psychiatry. 2014 Jun; 38(3):345-9.
Score: 0.004
-
Serotonin syndrome produced by a combination of fluoxetine and lithium. Am J Psychiatry. 1993 Oct; 150(10):1565.
Score: 0.004
-
Training physician-scientists: a model for integrating research into psychiatric residency. Acad Psychiatry. 2011 Jan-Feb; 35(1):40-5.
Score: 0.003
-
Medical treatment of alcohol dependence: a systematic review. Int J Psychiatry Med. 2011; 42(3):227-66.
Score: 0.003
-
Routine assessment of patient-reported outcomes in behavioral health: room for improvement. Qual Manag Health Care. 2010 Jan-Mar; 19(1):70-81.
Score: 0.003
-
Treatment of social anxiety with paroxetine: mediation of changes in anxiety and depression symptoms. Compr Psychiatry. 2009 Mar-Apr; 50(2):135-41.
Score: 0.003
-
A complex relationship between co-occurring social anxiety and alcohol use disorders: what effect does treating social anxiety have on drinking? Alcohol Clin Exp Res. 2008 Jan; 32(1):77-84.
Score: 0.003
-
Bupropion-SR in treatment of social phobia. Depress Anxiety. 2000; 12(2):111-3.
Score: 0.002
-
Feasibility of using fMRI to study mothers responding to infant cries. Depress Anxiety. 1999; 10(3):99-104.
Score: 0.002
-
Discontinuation of clonazepam in the treatment of social phobia. J Clin Psychopharmacol. 1998 Oct; 18(5):373-8.
Score: 0.001
-
Assessment of a new self-rating scale for post-traumatic stress disorder. Psychol Med. 1997 Jan; 27(1):153-60.
Score: 0.001
-
The neurobiology of social phobia. Int Clin Psychopharmacol. 1996 Jun; 11 Suppl 3:43-8.
Score: 0.001